Clifford J. Bailey PhD, FRCP(Edin), FRCPathProfessor of Clinical Science, Aston University, Birmingham, United Kingdom
Cliff Bailey is Professor of Clinical Science and Director of Biomedical Sciences Research at Aston University in Birmingham, England. He is a Fellow of the Royal College of Physicians of Edinburgh and a Fellow of the Royal College of Pathologists. He has been a Royal Society visiting scientist at the University of Southern California, Los Angeles, and a visiting scientist at Hanover Medical School in Germany. He has served on medical and scientific committees of Diabetes UK (formerly the British Diabetic Association), Society for Endocrinology, and European Association for the Study of Diabetes. Professor Bailey has held various editorial positions, including endocrine section editor of the British Journal of Pharmacology and editorial board member of Diabetes, Obesity and Metabolism, and Primary Care Diabetes. He is presently editor of the British Journal of Diabetes and Vascular Disease and senior editor of Diabetes and Vascular Disease Research. He has been an expert witness for drug licensing authorities, regulatory agencies and other national and international review bodies. His research is mainly directed towards the pathogenesis and treatment of diabetes, especially the development of new agents to improve insulin action and reduce obesity, and the therapeutic application of surrogate beta-cells. He has published extensively with over 350 research papers and reviews, and four books.
Recent Contributions to PracticeUpdate:
- Risk of Anemia With Metformin Use in Type 2 Diabetes
- Cardiovascular Risk Following Metformin Treatment in Patients With Type 2 Diabetes
- Metformin Extended-Release Is as Safe and Effective as Metformin Immediate-Release
- Potential Mechanisms of GLP-1 Modulation by Metformin
- MY APPROACH to Use of Metformin in Patients With CKD